Zentiva Pharma UK Ltd
- Country
- United Kingdom
- Reference
- GB-COH-02158996
Zentiva Pharma UK Ltd supplies pharmaceuticals and medical equipment to NHS England, Northern Ireland and London public buyers, with 14 public contract awards. Its 14 awards total approximately £223,262,741 across 2024 to 2026, with 2025 the busiest year at 8 awards. NHS England is the main buyer, awarding nine contracts, while the Regional Business Services Organisation, Procurement and Logistics Service and the Procurement & Logistics Service together account for five more. Several of the largest awards are NHS National Framework agreements, so the £37,694,000 denosumab framework (NHS England, September 2025) and the £14,758,000 nintedanib and dalbavancin framework (NHS England, February 2026) show the ceiling for all suppliers on each agreement, not the sum paid to this company. The most recent award is a generic medicinal products lot (Group 18) for £6,600 dated July 2026.
Interested in tenders like the ones Zentiva Pharma UK Ltd wins? Get the next public tenders published in the United Kingdom in the same sectors and from the same buyers, by email. Free, no card needed.
Activity of Zentiva Pharma UK Ltd in public procurement
By sector (CPV)
| CPV code | Awards |
|---|---|
| Pharmaceutical products 33600000 | 14 |
Activity by year
Recent awards
Open in El Vínculo →- NHS National Framework for Transition Products (Nintedanib and Dalbavancin) 25 February 2026
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin £25,881,00025 November 2025
- Project/Contract NHS National Framework for Denosumab Injection 30 September 2025
- NHS National Framework for Transition products (Nilotinib and Ticagrelor) 12 June 2025
- NHS National Framework for Transition products (Nilotinib and Ticagrelor) 12 June 2025
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 £6,600
- NHS National Framework for Transition Products (Nintedanib and Dalbavancin) £14,758,000
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin £25,881,000
- Generic, Branded Generic & Proprietary Medicinal Products - Group 17 £78,816
- NHS National Framework for Denosumab Injection commencing 1st January 2026
Contracting authorities that award contracts to Zentiva Pharma UK Ltd
By region
| Place of performance | Awards |
|---|---|
| Inner London — East | 1 |
By amount range
Keywords
How can I find out about tenders like the ones Zentiva Pharma UK Ltd wins?
Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders come out in the United Kingdom in the same CPV codes and from the same buyers. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.
Explore more tenders
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.